Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Jan;207(1):7-13.
doi: 10.1097/00000658-198801000-00003.

Postoperative complications and mortality after surgery for gastric cancer

Affiliations
Comparative Study

Postoperative complications and mortality after surgery for gastric cancer

A Viste et al. Ann Surg. 1988 Jan.

Abstract

Complication rates and postoperative mortality were studied in 1010 consecutive patients entered into the Norwegian Stomach Cancer Trial. Twenty-eight per cent of the patients had one or more complications (31% of the men and 21% of the women). General complications (pneumonia, thromboembolic, and cardiac) were most frequent. The postoperative mortality rate for resected patients was 8.3% (63 of 763). Complication and mortality rates were highest for proximal resections (52% and 16%) followed by total gastrectomy (38% and 8%), subtotal resection (28% and 10%), and distal resection (19% and 7%). By logistic regression analysis it was found that age, sex, operative procedure, prophylactic antibiotics, and splenectomy were significantly related to postoperative complications. The odds ratio for complication for men versus women was 1.75: for no antibiotics versus antibiotic prophylaxis it was 2.5. Relative to distal resection the odds ratio for complications after subtotal resection was 2.2, for total gastrectomy was 3.9, and for proximal resection was 7.6. Age and sex were the only factors that affected operative mortality. The odds ratio for mortality for men versus women was 2.3. The odds ratio for operative mortality was 2.2 when the age of the patient increased with 10 years.

PubMed Disclaimer

References

    1. Cancer. 1969 Jun;23(6):1305-8 - PubMed
    1. Surg Gynecol Obstet. 1957 Apr;104(4):497-8 - PubMed
    1. Ann Thorac Surg. 1968 Oct;6(4):396-400 - PubMed
    1. Am J Surg. 1971 Oct;122(4):540-4 - PubMed
    1. Cancer. 1972 Sep;30(3):660-4 - PubMed

Publication types

MeSH terms

Substances